Arcturus Therapeutics to Host Key Opinion Leader (KOL) Presentation of ARCT-810 Phase 2 Interim Data for Ornithine Transcarbamylase (OTC) Deficiency

Stock Information for NanoViricides Inc.

Loading

Please wait while we load your information from QuoteMedia.